Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

Université de Montréal

$34,783.00

Novel silver nanoparticles as antibacterial agents

EF 2021-22

Résumé
We aim to extend the advantages of a low-cost technique for the environmentally friendly synthesis of bactericidal silver nanoparticles (Ag NPs). Ag NPs, with unique properties, designed deliberately for specific problems in the health care field will be produced using different types of plant extracts, essential oils and natural antibacterials. The unique synthesis protocol developed by our partner produces different sizes and morphologies of Ag(0) nanoparticles. The goal is to identify the conditions that will give the best synergies between the natural antibacterial coatings and silver nanoparticles, with the goal of developing products that have a unique capacity to eradicate drug resistant bacteria. We will investigate the antibacterial efficacy of these products, by testing their ability to kill several biofilm forming bacterial strains including: Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. We aim to gain detailed insight into the complex action of Ag NP on the bacteria, with the long-term goal of incorporating them into hydrogel scaffolds for the treatment of chronic diseases and tissue regeneration. Nanoparticles will be rigorously characterized using Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM), Single Particle Inductively Coupled Plasma Mass Spectroscopy (SP-ICP-MS) and Single Cell Inductively Coupled Plasma Mass Spectroscopy (SC-ICP-MS).
Programme
Collaborative Research and Development Grants
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
521908-2018
Name nom
Wilkinson, Kevin
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2018
Award amount
34783
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Installment
inst:4
Partie
1
Nb partie
4
Application title
Novel silver nanoparticles as antibacterial agents
Keyword
NSERC
Application summary
We aim to extend the advantages of a low-cost technique for the environmentally friendly synthesis of bactericidal silver nanoparticles (Ag NPs). Ag NPs, with unique properties, designed deliberately for specific problems in the health care field will be produced using different types of plant extracts, essential oils and natural antibacterials. The unique synthesis protocol developed by our partner produces different sizes and morphologies of Ag(0) nanoparticles. The goal is to identify the conditions that will give the best synergies between the natural antibacterial coatings and silver nanoparticles, with the goal of developing products that have a unique capacity to eradicate drug resistant bacteria. We will investigate the antibacterial efficacy of these products, by testing their ability to kill several biofilm forming bacterial strains including: Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. We aim to gain detailed insight into the complex action of Ag NP on the bacteria, with the long-term goal of incorporating them into hydrogel scaffolds for the treatment of chronic diseases and tissue regeneration. Nanoparticles will be rigorously characterized using Dynamic Light Scattering (DLS), Transmission Electron Microscopy (TEM), Single Particle Inductively Coupled Plasma Mass Spectroscopy (SP-ICP-MS) and Single Cell Inductively Coupled Plasma Mass Spectroscopy (SC-ICP-MS).